Italian Rx Price Cuts Are Brand Pharma’s Pain; Will They Even Be Generics’ Gain?
This article was originally published in The Pink Sheet Daily
Executive Summary
As Italy’s government turns the austerity screw, physicians will need to be convinced to adopt INN-based prescribing in order for sales to see a boost.